Trial record 1 of 1 for:
04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04234113 |
Recruitment Status :
Active, not recruiting
First Posted : January 21, 2020
Last Update Posted : March 7, 2024
|
Sponsor:
SOTIO Biotech AG
Collaborator:
SOTIO Biotech a.s.
Information provided by (Responsible Party):
Sotio Biotech Inc. ( SOTIO Biotech AG )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | August 2024 |
Estimated Study Completion Date : | November 2024 |